(Q44401122)

English

The Potent Somatostatin Analogue Vapreotide Does Not Decrease Pancreas-Specific Complications After Elective Pancreatectomy: A Prospective, Multicenter, Double-Blinded, Randomized, Placebo-Controlled Trial

scientific article published on April 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

The potent somatostatin analogue vapreotide does not decrease pancreas-specific complications after elective pancreatectomy: a prospective, multicenter, double-blinded, randomized, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

The Potent Somatostatin Analogue Vapreotide Does Not Decrease Pancreas-Specific Complications After Elective Pancreatectomy: A Prospective, Multicenter, Double-Blinded, Randomized, Placebo-Controlled Trial (English)

1 reference

10.1016/S1072-7515(03)00104-2

https://api.crossref.org/works/10.1016/S1072-7515(03)00104-2

23 December 2023

0 references

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S1072-7515(03)00104-2

https://api.crossref.org/works/10.1016/S1072-7515(03)00104-2

23 December 2023

author name string

Pancreatic Surgery Group

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Micheal G. Sarr

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691930

23 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691930

23 December 2023

publication date

1 April 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S1072751503001042?httpAccept=text/xml

1 reference

10.1016/S1072-7515(03)00104-2

https://api.crossref.org/works/10.1016/S1072-7515(03)00104-2

23 December 2023

https://api.elsevier.com/content/article/PII:S1072751503001042?httpAccept=text/plain

1 reference

10.1016/S1072-7515(03)00104-2

https://api.crossref.org/works/10.1016/S1072-7515(03)00104-2

23 December 2023

https://journals.lww.com/00019464-200304000-00008

1 reference

10.1016/S1072-7515(03)00104-2

https://api.crossref.org/works/10.1016/S1072-7515(03)00104-2

23 December 2023

Journal of the American College of Surgeons

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

196

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

556-64; discussion 564-5; author reply 565

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of octreotide in the prevention of postoperative complications following pancreatic resection

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled multicentre trial of somatostatin infusion after pancreaticoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management.

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The complications of pancreatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1072-7515%2803%2900104-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1072-7515(03)00104-2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44401122&oldid=2034973256"